Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment

Journal of Surgical Research

Volumn 175, Issue 2, 2012, Pages 289-297

  Kanaan, Ziad ^b   Gardner, Sarah ^b   Carruba, Christopher ^b   Mattingly, Jameson ^b   Druen, Devin ^b   Cheadle, William G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

cytokine; peritonitis; tolerance; Toll like receptors

Indexed keywords

CHUK PROTEIN; ENDOTOXIN; GENTAMICIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 6; PROTEIN MD 2; RNA; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CANONICAL ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INTRAHEPATIC CHOLESTASIS; KLEBSIELLA PNEUMONIAE; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PATTERN RECOGNITION; PERITONEAL EXUDATE CELL; PERITONEUM LAVAGE; PERITONITIS; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; CHAPERONIN 60; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; I-KAPPA B KINASE; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; PERITONEUM; PERITONITIS; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84860767704     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.051     Document Type: Article

References (69)

1. T. Calandra, and J. Cohen The international sepsis forum consensus conference on definitions of infection in the intensive care unit Crit Care Med 33 2005 1538
2. A.M. Lenz, M. Turina, and P. Alard Microbial tolerance in secondary peritonitis is dose dependent Cell Immunol 258 2009 98
3. J.C. Marshall Intra-abdominal infections Microbes Infect 6 2004 1015
4. H.L. Evans, D.P. Raymond, and S.J. Pelletier Diagnosis of intra-abdominal infection in the critically ill patient Curr Opin Crit Care 7 2001 117
5. T. Koperna, and F. Schulz Prognosis and treatment of peritonitis. Do we need new scoring systems? Arch Surg 131 1996 180
6. P.B. Beeson Tolerance to bacterial pyrogens. I. Factors influencing its development J Exp Med 86 1947 29
7. J.M. Cavaillon, and M. Adib-Conquy Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis Crit Care 10 2006 233
8. S.E. Greisman, E.J. Young, and W.E. Woodward Mechanisms of endotoxin tolerance. IV. Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin J Exp Med 124 1996 983
9. A.E. Medvedev, I. Sabroe, and J.D. Hasday Tolerance to microbial TLR ligands: Molecular mechanisms and relevance to disease J Endotoxin Res 12 2006 133
10. C.L. Karp, M. Wysocka, and X. Ma Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance Eur J Immunol 8 1998 3128
11. J. Mages, H. Dietrich, and R. Lang A genome-wide analysis of LPS tolerance in macrophages Immunobiology 212 2007 723
12. G.D. Virca, S.Y. Kim, and K.B. Glaser Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells J Biol Chem 64 1989 21951
13. H.W. Ziegler-Heitbrock, M. Frankenberger, and A. Wedel Tolerance to lipopolysaccharide in human blood monocytes Immunobiology 93 1995 217
14. M. Ackermann, M. Reuter, and S. Flohe Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock J Endotoxin Res 7 2001 105
15. L.M. Colletti, D.G. Remick, and D.A. Campbell Jr. LPS pretreatment protects from hepatic ischemia/reperfusion J Surg Res 57 1994 337
16. M.D. Lehner, and T. Hartung Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection Rev Physiol Biochem Pharmacol 144 2002 95
17. C.M. Mason, E. Dobard, and W.R. Summer Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms J Infect Dis 176 1997 1293
18. K.C. Milner Patterns of tolerance to endotoxin J Infect Dis 128 1973 (Suppl)45
19. A. Severn, D. Xu, and J. Doyle Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity Eur J Immunol 23 1993 1711
20. M.S. Jin, and J.O. Lee Structures of the Toll-like receptor family and its ligand complexes Immunity 29 2008 182
21. S. Akira TLR signaling Curr Top Microbiol Immunol 311 2006 1
22. M.A. West, and W. Heagy Endotoxin tolerance: A review Crit Care Med 30 2002 S64
23. S.K. Biswas, and E. Lopez-Collazo Endotoxin tolerance: New mechanisms, molecules and clinical significance Trends Immunol 30 2009 475
24. A.E. Medvedev, P. Henneke, and A. Schromm Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4 J Immunol 167 2001 2257
25. S. Sato, F. Nomura, and T. Kawai Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways J Immunol 165 2000 7096
26. S. Kastenbauer, and H.W. Ziegler-Heitbrock NF-κB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression Infect Immun 67 1999 1553
27. K. Wahlstrom, J. Bellingham, and J.L. Rodriguez Inhibitory κBα control of nuclear factor-κB is dysregulated in endotoxin tolerant macrophages Shock 11 1999 242
28. D.R. Woods, J.C. Peyton, and G.A. Franklin Decreased neutrophil response in a model of chronic intraperitoneal Klebsiella infection Surg Infect (Larchmont) 8 2007 367
29. A.M. Lenz, G.A. Franklin, and M. Fairweather Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis Cytokine 40 2007 207
30. SABiosciences Website (Help Manual). Available at: http://www. sabiosciences.com/mirna-pcr-array.php, 2010. Accessed November 2009.
31. Ingenuity Pathway Analysis Website (Help Manual). Available at: https://analysis.ingenuity.com/pa/info/help, 2010. Accessed November 2009.
32. J.F. Cailhier, M. Partolina, and S. Vuthoori Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation J Immunol 174 2005 2336
33. M.A. Freudenberg, and C. Galanos Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages Infect Immun 56 1988 1352
34. G.S. Madonna, and S.N. Vogel Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice Infect Immun 53 1986 707
35. A.M. Lenz, M. Qadan, and S.A. Gardner Impact of microbial tolerance in persistent secondary Klebsiella pneumoniae peritonitis Cytokine 53 2010 84
36. R. Shimazu, S. Akashi, and H. Ogata MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 189 1999 1777
37. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499
38. R.F. Schwabe, E. Seki, and D.A. Brenner Toll-like receptor signaling in the liver Gastroenterology 130 2006 1886
39. R.J. Carmody, and Y.H. Chen Nuclear factor-κB: Activation and regulation during Toll-like receptor signaling Cell Mol Immunol 4 2007 31
40. G. Zhang, and S. Ghosh Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors J Endotoxin Res 6 2000 453
41. K. Tanaka, T. Kawakami, and K. Tateishi Control of IκBα proteolysis by the ubiquitin-proteasome pathway Biochimie 83 2001 351
42. P. Viatour, M.P. Merville, and V. Bours Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation Trends Biochem Sci 30 2005 43
43. S. Gordon Pattern recognition receptors: Doubling up for the innate immune response Cell 111 2002 927
44. K. Chen, J. Huang, and W. Gong Toll-like receptors in inflammation, infection and cancer Int Immunopharmacol 7 2007 1271
45. J.R. Schurr, E. Young, and P. Byrne Central role of Toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria Infect Immun 73 2005 532
46. J.H. Wu, L.C. Hong, and Y.Y. Tsai Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae Cell Microbiol 8 2006 1467
47. M. Muzio, J. Ni, and P. Feng IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling Science 278 1997 1612
48. K.A. Fitzgerald, E.M. Palsson-McDermott, and A.G. Bowie Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction Nature 413 2001 78
49. M. Yamamoto, S. Sato, and H. Hemmi Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 Nature 420 2002 324
50. J.L. Swantek, M.F. Tsen, and M.H. Cobb IL-1 receptor-associated kinase modulates host responsiveness to endotoxin J Immunol 164 2000 4301
51. T. Kawagoe, S. Sato, and A. Jung Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling J Exp Med 204 2007 1013
52. J.L. Swantek, L. Christerson, and M.H. Cobb Lipopolysaccharide-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase-dependent J Biol Chem 274 1999 11667
53. J.R. Klune, R. Dhupar, and J. Cardinal HMGB1: Endogenous danger signaling Mol Med 14 2008 476
54. M.E. Bianchi DAMPs, PAMPs and alarmins: All we need to know about danger J Leukoc Biol 81 2007 1
55. L. Apetoh, F. Ghiringhelli, and A. Tesniere The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy Immunol Rev 220 2007 47
56. M.E. Bianchi, and A.A. Manfredi High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity Immunol Rev 220 2007 35
57. H. Kazama, J.E. Ricci, and J.M. Herndon Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein Immunity 29 2008 21
58. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248
59. M.T. Lotze, and K.J. Tracey High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331
60. E. Abraham, J. Arcaroli, and A. Carmody HMG-1 as a mediator of acute lung inflammation J Immunol 165 2000 2950
61. G. Chen, J. Li, and M. Ochani Bacterial endotoxin stimulates macrophages to release HMGB1 partly through J Leukoc Biol 76 2004 994
62. D. Tang, Y. Shi, and L. Jang Heat shock response inhibits release of high mobility group box 1 protein induced by endotoxin in murine macrophages Shock 23 2005 434
63. W. Jiang, C.W. Bell, and D.S. Pisetsky The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid J Immunol 178 2007 6495
64. B. Rendon-Mitchell, M. Ochani, and J. Li IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J Immunol 170 2003 3890
65. A. Rouhiainen, J. Kuja-Panula, and E. Wilkman Regulation of monocyte migration by amphoterin (HMGB1) Blood 104 2004 1174
66. H. Wahamaa, T. Vallerskog, and S. Qin HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay J Leukoc Biol 81 2007 129
67. J.H. Youn, and J.S. Shin Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion J Immunol 177 2006 7889
68. F. Cappello, C. Tripodo, and F. Farina HSP10 selective preference for myeloid and megakaryocytic precursors in normal human bone marrow Eur J Histochem 48 2007 261
69. P.A. Sieling, and R.L. Modlin Activation of Toll-like receptors by microbial lipoproteins Scand J Infect Dis 33 2001 97